Literature DB >> 17045587

Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate.

Holger Diez1, Andreas Fischer, Anja Winkler, Cheng-Jun Hu, Antonis K Hatzopoulos, Georg Breier, Manfred Gessler.   

Abstract

Adequate response to low oxygen levels (hypoxia) by hypoxia inducible factor (HIF) is essential for normal development and physiology, but this pathway may also contribute to pathological processes like tumor angiogenesis. Here we show that hypoxia is an inducer of Notch signaling. Hypoxic conditions lead to induction of the Notch ligand Dll4 and the Notch target genes Hey1 and Hey2 in various cell lines. Promoter analysis revealed that Hey1, Hey2 and Dll4 are induced by HIF-1alpha and Notch activation. Hypoxia-induced Notch signaling may also determine endothelial identity. Endothelial progenitor cells (EPCs) contain high amounts of COUP-TFII, a regulator of vein identity, while levels of the arterial regulators Dll4 and Hey2 are low. Hypoxia-mediated upregulation of Dll4 and Hey2 leads to repression of COUP-TFII in eEPCs. Finally, we show that Hey factors are capable of repressing HIF-1alpha-induced gene expression, suggesting a negative feedback loop to prevent excessive hypoxic gene induction. Thus, reduced oxygen levels lead to activation of the Dll4-Notch-Hey2 signaling cascade and subsequent repression of COUP-TFII in endothelial progenitor cells. We propose that this is an important step in the developmental regulation of arterial cell fate decision.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17045587     DOI: 10.1016/j.yexcr.2006.09.009

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  90 in total

Review 1.  Notch signaling in ocular vasculature development and diseases.

Authors:  Guo-Rui Dou; Lin Wang; Yu-Sheng Wang; Hua Han
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

2.  Acid treatment of melanoma cells selects for invasive phenotypes.

Authors:  Raymond E Moellering; Kvar C Black; Chetan Krishnamurty; Brenda K Baggett; Phillip Stafford; Matthew Rain; Robert A Gatenby; Robert J Gillies
Journal:  Clin Exp Metastasis       Date:  2008-02-27       Impact factor: 5.150

Review 3.  Hypoxia, notch signalling, and prostate cancer.

Authors:  Laure Marignol; Karla Rivera-Figueroa; Thomas Lynch; Donal Hollywood
Journal:  Nat Rev Urol       Date:  2013-05-28       Impact factor: 14.432

Review 4.  Hey bHLH factors in cardiovascular development.

Authors:  Cornelia Wiese; Julia Heisig; Manfred Gessler
Journal:  Pediatr Cardiol       Date:  2009-12-24       Impact factor: 1.655

Review 5.  Generating specificity and diversity in the transcriptional response to hypoxia.

Authors:  Urban Lendahl; Kian Leong Lee; Henry Yang; Lorenz Poellinger
Journal:  Nat Rev Genet       Date:  2009-11-03       Impact factor: 53.242

Review 6.  Ocular neovascularization.

Authors:  Peter A Campochiaro
Journal:  J Mol Med (Berl)       Date:  2013-01-18       Impact factor: 4.599

7.  Low oxygen tension enhances endothelial fate of human pluripotent stem cells.

Authors:  Sravanti Kusuma; Elizabeth Peijnenburg; Parth Patel; Sharon Gerecht
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-02-13       Impact factor: 8.311

Review 8.  Notch: A multi-functional integrating system of microenvironmental signals.

Authors:  Bryce LaFoya; Jordan A Munroe; Masum M Mia; Michael A Detweiler; Jacob J Crow; Travis Wood; Steven Roth; Bikram Sharma; Allan R Albig
Journal:  Dev Biol       Date:  2016-08-24       Impact factor: 3.582

Review 9.  Impact of notch signaling on inflammatory responses in cardiovascular disorders.

Authors:  Thibaut Quillard; Beatrice Charreau
Journal:  Int J Mol Sci       Date:  2013-03-26       Impact factor: 5.923

10.  Notch1 functions as a negative regulator of lymphatic endothelial cell differentiation in the venous endothelium.

Authors:  Aino Murtomaki; Minji K Uh; Yun K Choi; Christopher Kitajewski; Valeriya Borisenko; Jan Kitajewski; Carrie J Shawber
Journal:  Development       Date:  2013-04-24       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.